Header Logo

Connection

Jonathan Wren to Angiogenesis Inhibitors

Back to Details
This is a "connection" page, showing publications Jonathan Wren has written about Angiogenesis Inhibitors.
Jonathan Wren
Connection Strength
0.131
Angiogenesis Inhibitors
  1. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Neuro Oncol. 2017 02 01; 19(2):175-185.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.